Stress in adolescence has been widely demonstrated to have a lasting impact in humans and animal models. Developmental risk and protective factors play an important role in the responses to stress in adulthood. Mild-to-moderate stress in adolescence may resist the negative impacts of adverse events in adulthood. However, little research on resilience has been conducted. In this study, we used a predictable chronic mild stress (PCMS) procedure (5 min of daily restraint stress for 28 days) in adolescent rats (postnatal days (PNDs) 28-55) to test the resilience effect of PCMS on depressive-like behavior in the sucrose preference test and forced swim test and anxietylike behavior in the novelty-suppressed feeding test and elevated plus maze in adulthood. We also investigated the role of mammalian target of rapamycin (mTOR) signaling in the brain during the PCMS procedure in adolescence. Moreover, we investigated the effect of PCMS in adolescence on subsequent responses to chronic unpredictable stress (CUS; PNDs 63-83) in adulthood. The results demonstrated that PCMS during adolescence produced antidepressant-and anxiolytic-like effects and increased mTOR signaling activity in the prefrontal cortex in early adulthood. Either systemic administration or intra-PFC infusion of the mTOR inhibitor rapamycin completely blocked the behavioral effects produced by PCMS in adolescence. PCMS during adolescence resisted depressive-and anxiety-like behavior caused by CUS in adulthood. These findings indicate that PCMS in adolescence can contribute to resilience against depression and anxiety caused by stress in adulthood.
INTRODUCTION
Adolescence is a critical period of development during the transition from childhood to adulthood, and it is a key time point for the maturation of social and cognitive behavior in preparation for adulthood. It is defined by characteristic adolescent behaviors, including high levels of risk-taking, high exploration, novelty-and sensationseeking, social interaction, high activity, and play behaviors that likely promote the acquisition of the necessary skills for maturation and independence (Spear, 2000) . In rodents, the ages associated with adolescence are commonly considered to be postnatal days (PNDs) 21-59 (Tirelli et al, 2003) .
Compared with adulthood, adolescence is a critical time window for stress susceptibility (Heim and Nemeroff, 2001 ). Stress during adolescence may have enduring consequences on mental health later in life. However, not all individuals who encounter stress or adverse events develop mental illnesses, and responses to stress vary widely (Southwick and Charney, 2012) . Stress experienced during adolescence often leads to increased risk for the development of mental health problems in adulthood. Animal models indicated that stress during adolescence increased depressive-and anxiety-like behavior in adulthood (McCormick et al, 2008; Pohl et al, 2007) . Conflicting studies have reported that adverse experiences during development promote resilience to adverse or stressful environments in adulthood. For example, intermittent predatory stress in adolescent rats was reported to induce greater resilience in adulthood (Kendig et al, 2011) . Toth et al's (2008) research found that chronic mild stress at a young age was less or even not harmful to brain plasticity and the associated risk of depressive behavior.
The consequences of stress may also be related to its predictable or unpredictable nature (Anisman and Matheson, 2005) . Unpredictable chronic mild stress always leads to depressive-and anxiety-like behavior (Zhu et al, 2011) , but predictable chronic mild stress (PCMS) enhanced mood, learning, and memory in adult rats by stimulating neural stem cells and increasing neurogenesis in the hippocampus (Parihar et al, 2011) . PCMS is characterized by predictability, mild intensity, and an appropriate duration of stress exposure (eg, predictable 5 min restraint stress daily for 28 days in Parihar's research). Although PCMS decreased depressive-and anxiety-like behavior for prolonged periods (Parihar et al, 2011) , no study of which we are aware has reported the effects of adolescent exposure to PCMS on subsequent depressive-and anxiety-like behavior in adulthood.
Many signaling pathways have been shown to be engaged in depressive-like behavior, including the mammalian target of rapamycin (mTOR) pathway. mTOR is a conserved serine/threonine protein kinase involved in cellular translation, the control of neuronal cell size (Kwon et al, 2003) , local protein synthesis in dendrites (Takei et al, 2004) , and synaptic plasticity (Cammalleri et al, 2003) . mTOR phosphorylates p70-kDa ribosomal protein S6 kinase and subsequently phosphorylates the S6 ribosomal protein (rpS6; Chandran et al, 2012) . Recent research provided evidence that the mTOR pathway have an important role in depression. Li et al (2010 Li et al ( , 2011 reported that the rapid antidepressant effects of ketamine were mediated by activation of the mTOR signaling pathway in the prefrontal cortex (PFC), and blockade of mTOR signaling by rapamycin completely blocked ketamine-induced molecular and behavioral alterations.
In this study, we hypothesized that (1) exposure to PCMS during adolescence provides resilience to depressive-and anxiety-like behavior in adulthood, (2) the central mTOR signaling pathway is involved in the resistance effect of PCMS during adolescence on the development of depression and anxiety in adulthood, and (3) exposure to PCMS during adolescence promotes resilience to depressive-and anxiety-like behavior induced by chronic unpredictable stress (CUS) in adulthood.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats, aged 21 days, weighed 45-55 g upon arrival to the laboratory and were housed in groups of four per cage. The animals were allowed 1 week of acclimatization after arrival before commencing stress exposure. The experiment began on PND 28. All of the animals were housed in temperature-controlled (23±2 1C) and humidity-controlled (50±5%) rooms and maintained on a 12 h/12 h light/dark cycle (lights on 0800 hours) with food and water available ad libitum. All of the animal procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and the procedures were approved by the Local Animal Use Committee.
Predictable Chronic Mild Stress
The PCMS protocol was adapted from a previous report (Parihar et al, 2011) . A rat restrainer was constructed of stainless steel with a grid of holes on the head side for ventilation and a sliding door on the tail side. The size of the restrainer was adjusted to the growth of the animals. The rats were restrained for 5 min each day with no mobility and then were returned to their home cage. This stress paradigm continued for 28 days, during which all of the rats were restrained at the same time every day (1500-1700 hours) to maintain the predictability of the timing of stress.
Chronic Unpredictable Stress
The CUS protocol was adapted from previous reports with minor modifications (Li et al, 2011; Willner et al, 1987; Zhu et al, 2011) . The animals were exposed to a variable sequence of mild and unpredictable stressors for 21 days. A total of 10 different stressors were used, with two stressors per day. The stressors included cold for 1 h at 4 1C, water deprivation for 24 h, vibration for 1 h, tilted cages (451) for 24 h, forced cold swim for 5 min, crowding for 24 h, soiled bedding for 24 h, light/dark cycle reversal for 36 h, food deprivation for 24 h, and tail clamp for 1 min.
Sucrose Preference Test
The sucrose preference is considered an index of anhedonia (Shi et al, 2012; Warner-Schmidt and Duman, 2008) . The rats were trained to adapt to a 1% sucrose solution (w/v) for 48 h at the beginning of the experiment, in which two bottles of 1% sucrose solution were placed in each cage. After adaptation, the rats were deprived of water for 4 h, followed by the sucrose preference test (SPT), in which rats were housed in individual cages for 1 h exposure to two identical bottles, one filled with 1% sucrose solution and the other filled with water. At the end of the 1 h test, sucrose and water consumption (in ml) was measured. Sucrose preference (%) was calculated as sucrose consumption/(sucrose consumption þ water consumption). All of the behavioral tests and drug administrations were performed during the dark phase.
Locomotor Activity Test
Locomotor activity was measured with an automated video tracking system (DigBehv-LM4; Shanghai Jiliang Software Technology, Shanghai, China) that contained eight identical clear Plexiglas chambers (40 cm Â 40 cm Â 65 cm). The video files were analyzed using DigBehv analysis software. Locomotor activity is expressed as the total distance traveled in centimeters during a predetermined period of time (in 5 min).
Novelty-Suppressed Feeding Test
The novelty-suppressed feeding test (NSFT) was adapted from previous protocols (Bodnoff et al, 1988; Zhu et al, 2011) . The rats were deprived of food for 24 h before the test in their home cages. On the test day, the rats were individually placed in an open field arena (75 cm Â 75 cm Â 40 cm) with several small pellets of food placed on a piece of white paper (10 cm Â 10 cm) in the center. Each rat was first placed in a corner of the cage. The latency to approach the food and begin eating was recorded (in s) as the main test parameter (maximum time, 10 min). Immediately after each rat was taken back to its home cage, food consumption during the first 5 min (mg/kg bodyweight) was quantified to exclude the possibility that stress affected normal appetite and feeding. A more 'anxious' animal will take more time to begin eating in a novel environment (Bodnoff et al, 1988) .
Elevated Plus Maze
The elevated plus maze (EPM) is based on a rat's natural fear of open, unprotected, and elevated spaces (Parihar et al, 2011; Pellow et al, 1985) . The EPM consisted of four crossed narrow arms elevated 70 cm from the floor (50 cm long and 10 cm wide), with two open arms and two closed arms with 40 cm high walls. Illumination was 3 lx in the closed arms and 8 lx in the open arms. Each rat was first placed in the central zone of the EPM with its head facing an open arm. The rat was allowed to freely explore the maze for 5 min. The number of entries into and time (in s) spent in the open arms were recorded by two independent observers who were blind to the group assignments and sat quietly at a distance of 2.5 m from the maze.
Forced Swim Test
The forced swim test (FST) is a well-established behavioral model of despair (Porsolt et al, 1978; Zhu et al, 2011) . Each rat was first individually placed into a 25 cm diameter Â 65 cm height plastic cylinder filled with water that was maintained at 23-25 1C to a depth of 45 cm for 15 min. The rats were removed from the water at the end of 15 min, gently dried, and returned to their home cages. They were placed again in the cylinders 24 h later, and the 5 min FST was conducted. Immobility (in s) was recorded by two independent observers who were blind to the animal groups. Floating was defined as the minimum movement necessary to keep the rat's head above the water.
Drugs Administration and Surgical Procedure
Rapamycin (Sigma, St Louis, MO) was dissolved in 100% dimethyl sulfoxide (DMSO; Sigma) for systemic administration of 10 mg/kg (intraperitoneally). The vehicle for the control treatment was 100% DMSO (Neasta et al, 2010) . For experiments that involved central administration of the inhibitor, surgical procedures began 5 days after the adolescent PCMS paradigm described above. When the rats' body weights reached 280-310 g, they were implanted with guide cannulae (22 gauge) into the medial PFC (coordinates from bregma: anterior/posterior, þ 3.2 mm; medial/lateral, ± 1.0 mm; dorsal/ventral, À 3.0 mm from dura; Li et al, 2010) . The rats were anesthetized with sodium pentobarbital (50 mg/kg, intraperitoneally; Shi et al, 2012) . After a 7-day recovery period, rapamycin (0.01 nmol in 1 ml) or vehicle (DMSO) was delivered 3 h before each behavioral test at a rate of 0.25 ml/min, with the injection cannula (26 gauge) protruding 1 mm beyond the guide cannula. The dose was chosen based on Li et al (2010) . The injection cannula stayed in the guide cannula for 1 min after the infusions.
Tissue Sample Preparation
The brains were extracted, and bilateral tissue punches (13 gauge) of the PFC, hippocampus, and amygdala were obtained based on our previous study (Lu et al, 2005; Shi et al, 2012) . The tissue punches were homogenized (10-15 s Â 3, 5 s interval) with an electrical disperser (Wiggenhauser, Sdn Bhd) after being lysed with RIPA lysis buffer with protease inhibitor and a phosphatase inhibitor mixture (Applygen Technology, Beijing, China) for 30 min. Afterwards, the homogenate was subjected to 10 000 g centrifugation at 4 1C for 20 min. All of the above procedures were performed at low temperature (0-41C). The protein concentrations of all of the samples were determined using the BCA assay kit (Applygen Technology). The protein concentration was normalized by diluting the samples with RIPA lysis buffer.
Western Blot Assays
The samples were treated according to our previous studies (Wang et al, 2010) . Briefly, equal amounts of protein (40 mg) for each sample were loaded into 8% or 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The primary antibodies used were as follows: anti-phosphomTOR (1 : 1000, Ser2448; Cell Signaling Technology), anti-mTOR (1 : 1000; Cell Signaling Technology), antiphospho-rpS6 (1 : 500, Ser235/236; Cell Signaling Technology), anti-rpS6 (1 : 1000, 5G10; Cell Signaling Technology), anti-b-actin antibody (1 : 2000, A5316; Sigma), and horseradish peroxidase-conjugated secondary antibody (1 : 5000, goat anti-rabbit or mouse IgG; Santa Cruz Biotechnology and Vector Laboratories, respectively). The levels of all of the molecules were normalized to the level of b-actin. Band intensities were quantified by two observers who were blind to the experimental groups using the Quantity One 4.0.3 software (Bio-Rad, Hercules, CA).
Data Analysis
The data are expressed as mean ± SEM. The statistical analysis of the behavioral and molecular data in the two groups was performed using Student's t-test. For the other experiments, the data were analyzed using two-way analysis of variance (ANOVA), followed by the least significant difference post hoc test (for details, see the Results section; Shi et al, 2012) . Values of po0.05 were considered statistically significant.
RESULTS
PCMS in Adolescence Produced Antidepressant-and Anxiolytic-Like Effects and Increased mTOR Activity in the PFC in Early Adulthood
The rats were exposed to PCMS within the adolescent period (ie, PNDs 28-55), which continued for 28 days. On PND 28, the rats were randomly assigned to two groups (n ¼ 9-10 per group). One group of rats underwent the PCMS procedure for 28 days. The other rats were assigned to the control group and underwent similar handling every day for 28 days, with the exception of restraint stress. Behavioral tests began on PND 62, and each rat was subjected to the SPT, locomotor activity assessment, the NSFT, the EPM, and the FST to assess depressive-and anxiety-like behavior. The tests were conducted sequentially, one per day, to minimize the impact of immediate behavioral testing on subsequent tests. The timeline is shown in Figure 1a . PCMS during adolescence had no effects on body weight gain (p40.05; Figure 1b ), sucrose preference (p40.05; Figure 1c ), or locomotor activity (p40.05; Figure 1d ). PCMS produced anxiolytic-like effects, reflected by an decreased latency to feed (t 17 ¼ 2.33, po0.05; Figure 1e ), without altering home cage food consumption in the NSFT (p40.05; Figure 1f ). PCMS significantly increased the time spent in the open arms (t 17 ¼ À 4.19, po0.05; Figure 1g ) and the number of entries into the open arms of the EPM (t 17 ¼ À 2.53, po0.05; Figure1h). PCMS produced antidepressant-like effects, reflected by a significant decrease in immobility in the FST (t 17 ¼ 3.08, po0.05; Figure 1i ).
One day after all of the behavioral tests ended, the brains were removed for subsequent measurement of mTOR signaling activity. Six samples were randomly selected for the assessment of phospho-mTOR (Ser2448) and phosphorpS6 (Ser235/236) levels using western blot (n ¼ 6 per group; Wang et al, 2010) . In rats that were subjected to PCMS, the levels of phospho-mTOR (t 10 ¼ À 7, po0.05; Figure 2a ) and phospho-rpS6 (t 10 ¼ À 5.84, po0.05; Figure 2c ) were significantly elevated in the PFC but not in the hippocampus (Figure 2e and g) or amygdala ( Figure 2i and k) compared with the control groups. However, total mTOR and rpS6 levels were not significantly changed in these brain regions (Figure 2b , d, f, h, j and l), reflected by increased mTOR signaling activity in the PFC. Altogether, these results suggest that PCMS during adolescence effectively resisted depressive-and anxiety-like behavior in early adulthood and elevated mTOR signaling activity in the PFC.
Systemic Inhibition of mTOR Signaling Activity Reversed the Antidepressant-and Anxiolytic-Like Behavior Produced by PCMS During Adolescence
To determine the relationship between mTOR signaling and the antidepressant-and anxiolytic-like effects of PCMS exposure during adolescence, four groups of rats (n ¼ 10-11 per group) were assigned to PCMS or non-PCMS conditions during adolescence and then received vehicle (DMSO) or rapamycin (10 mg/kg, intraperitoneally) during early adulthood. Rapamycin was administered 3 h before each behavioral test. All of the behavioral tests were separated by 1 day and were conducted sequentially after stress exposure. The timeline of this experiment is shown in Figure 3a . Rapamycin did not influence sucrose preference (p40.05; Figure 3b ) or locomotor activity (p40.05; Figure 3c ). Rapamycin completely blocked the resilience effects of PCMS during adolescence, reflected by no changes in the latency to feed (p40.05; Figure 3d Predictable chronic mild stress (PCMS) during adolescence increased mammalian target of rapamycin (mTOR) signaling activity in the prefrontal cortex (PFC). After the rats were exposed to PCMS and the behavioral tests, the levels of total and phosphorylated (p)-mTOR and S6 ribosomal protein (rpS6) were determined in the PFC, hippocampus (Hip), and amygdala (Amy) by western blot. The levels of p-mTOR and p-rpS6 (a, c) were increased in the PFC, suggesting that PCMS during adolescence increased mTOR signaling activity in the PFC. The levels of p-mTOR and p-rpS6 were not altered in the Hip (e, g) or Amy (i, k). Total mTOR and rpS6 levels were not changed in these brain regions (b, d, f, h, j and l) . The data are expressed as mean ± SEM. Representative band intensities of the western blot are shown on the bottom (n ¼ 6 per group). *po0.05, compared with the control group.
entries into the open arms in the EPM (p40.05; Figure 3f , g), and immobility in the FST (p40.05; Figure 3h ), compared with the control groups. A two-way ANOVA, with inhibitor treatment (vehicle and rapamycin) and stress (non-PCMS and PCMS) (a) Schematic of the timeline for PCMS exposure, drug administration, and the behavioral tests. Vehicle (Veh) or Rapa (10 mg/kg, intraperitoneally) was injected 3 h before each behavioral test. All of the behavioral tests were separated by 1 day and conducted sequentially after stress exposure. We assessed the effects of Rapa on (b) depressive-like behavior in the sucrose preference test (SPT), (c) locomotor activity, (d, e) anxiety-like behavior in the novelty-suppressed feeding test (NSFT), reflected by the latency to feed and food consumption during 5 min in the home cages, (f, g) anxiety-like behavior in the elevated plus maze (EPM), and (h) depressive-like behavior in the forced swim test (FST). The data are expressed as mean ± SEM (n ¼ 10-11 per group). *po0.05, compared with the control group; # po0.05, PCMS-Rapa group compared with PCMS-Veh group. LA, locomotor activity.
(F 1,37 ¼ 12.61, po0.05) were found for immobility in the FST (Figure 3b-h) . One day after the behavioral tests, the brains were removed, and six samples were randomly selected for subsequent western blot (n ¼ 6 per group; Wang et al, 2010) . The data analysis showed that rapamycin completely blocked the effect of PCMS on the elevations of phosphomTOR and phospho-rpS6 levels in the PFC compared with the control groups and did not change phospho-mTOR or phospho-rpS6 levels in the PFC in the control groups (p40.05; Figure 4a and (Figure 4a and c) . The levels of phospho-mTOR and phospho-rpS6 in the hippocampus (Figure 4e and g ) and amygdala (Figure 4i and k) were not significantly changed in the four groups, and total mTOR and rpS6 levels were not significantly changed in these three brain regions in the four groups (p40.05; Figure 4b , d, f, h, j and l).
Altogether, these results indicate that systemic rapamycin administration completely reversed the antidepressant-and anxiolytic-like behavior produced by PCMS during adolescence, and these effects were mediated by mTOR signaling in the PFC.
Intra-PFC Infusion of Rapamycin Reversed the Antidepressant-and Anxiolytic-Like Behavior Produced by PCMS During Adolescence
To further determine the relationship between mTOR signaling in the PFC and antidepressant-and anxiolyticlike effects of PCMS exposure during adolescence, four groups of rats (n ¼ 10 per group) were also assigned to PCMS and non-PCMS conditions during adolescence and then received vehicle (DMSO) or rapamycin (0.01 nmol, PFC) during early adulthood. Rapamycin was administered 3 h before each behavioral test. All of the behavioral tests were separated by 1 day and were conducted sequentially after stress exposure. The timeline of this experiment is shown in Figure 5a . Rapamycin did not influence sucrose preference (p40.05; Figure 5b ) or locomotor activity (p40.05; Figure 5c ) and completely blocked the resilience effects of PCMS during adolescence, reflected by no changes in the latency to feed (p40.05; Figure 5d ), without altering home cage food consumption in the NSFT (p40.05; Figure 5e ), the time spent in the open arms or number of entries into the open arms in the EPM (p40.05; Figure 5f , g), and immobility time in the FST (p40.05; Figure 5h ), compared with the control groups. A two-way ANOVA, with inhibitor treatment (vehicle and rapamycin) and stress (non-PCMS and PCMS) as the between-subjects factors, was used to analyze the effects of mTOR inhibition on the behavioral measures. The analysis revealed no significant main effects or interactions (all p40.05) for sucrose preference, locomotor activity, or home cage food consumption in the NSFT. Significant main effects of treatment (F 1,36 ¼ 7.01, po0.05) and stress (F 1,36 ¼ 4.31, po0.05) and a significant treatment Â stress interaction (F 1,36 ¼ 6.02, po0.05) were found for the latency to feed in the NSFT. (Figure 5b-h) .
One day after the behavioral tests, the brains were removed, and six samples were randomly selected for subsequent western blot (n ¼ 6 per group; (Wang et al, 2010) . The data analysis showed that rapamycin completely blocked the effect of PCMS on the elevations of phosphomTOR and phospho-rpS6 levels in the PFC compared with the control groups and did not change phospho-mTOR or phospho-rpS6 levels in the PFC in the control groups (p40.05; Figure 6a and (Figure 6a and c) . Total mTOR and rpS6 levels were not significantly changed in the PFC in the four groups (p40.05; Figure 6b and d) .
Altogether, these results indicate that the antidepressantand anxiolytic-like behaviors produced by PCMS during adolescence were mediated by mTOR signaling in the PFC.
PCMS in Adolescence Resisted CUS-Induced Depressive-and Anxiety-Like Behavior in Adulthood
Four groups of rats were used in a 2 (non-PCMS and PCMS) Â 2 (non-CUS and CUS) factorial design to test the effects of PCMS during adolescence (PNDs 28-55) on responses to CUS (PNDs 63-83) in adult rats (n ¼ 9-10 per group). Briefly, 7 days after the PCMS procedure (ie, PND 63), the rats in the PCMS group were separated into two groups. One group underwent CUS for 21 days, and the other rats were assigned to the control group. The non-PCMS control group was also separated into two groups: CUS and control. At 2 days after CUS (ie, PND 86), all of the behavioral tests were performed sequentially to measure depressive-and anxiety-like behavior. The timeline of this experiment is shown in Figure 7a .
Body weight gain in the group exposed to PCMS followed by CUS was significantly less than in the control and PCMS groups (po0.05), but significantly more than in the CUS group (po0.05; Figure 7b ). Locomotor activity was not influenced by stress in adolescence or adulthood (p40.05; Figure 7d ). However, PCMS during adolescence resisted the depressive-like behavior induced by CUS during adulthood, measured in the SPT and FST (Figure 7c and i) , and anxiety-like behavior, measured in the NSFT and EPM (Figure 7e-h) . A two-way ANOVA, with stress in adolescence (non-PCMS and PCMS) and stress in adulthood (non-CUS and CUS) as the between-subjects factors, revealed main effects of stress in adolescence (F 1,35 ¼ 12.10, po0.05) and stress in adulthood (F 1,35 ¼ 291.75, po0.05) and a stress Figure 4 Systemic rapamycin (Rapa) resisted the elevation of mammalian target of Rapa (mTOR) signaling activity in the prefrontal cortex (PFC). After the rats were exposed to predictable chronic mild stress (PCMS), drug administration, and the behavioral tests, the levels of total and phosphorylated (p) mTOR and S6 ribosomal protein (rpS6) in the PFC, hippocampus, and amygdala were determined by western blot. Rapa blocked the elevation of p-mTOR and p-rpS6 levels in the PFC compared with the control groups (a, c) and did not change p-mTOR or p-rpS6 levels in the hippocampus (Hip) (e, g) or amygdala (Amy) (i, k). Total mTOR and rpS6 levels were not significantly changed in the PFC (b, d), Hip (f, h), or Amy (j, l) in the four groups. The data are expressed as mean ± SEM. Representative band intensities of the western blot are shown on the bottom (n ¼ 6 per group (Figure 7c) . No significant main effects or interactions were found for locomotor activity (all p40.05; Figure 7d ). Main effects of stress in adolescence (F 1,35 ¼ 12.62, po0.05) and stress in adulthood (F 1,35 ¼ 11.83, po0.05) and a stress in adolescence Â stress in adulthood interaction (F 1,35 ¼ 6.73, po0.05) were found for the latency to feed in the NSFT (Figure 7e ), but no significant main effects or interactions were found for home cage food consumption (all p40.05; Figure 7f (Figure 7g ) and the number (Figure 7h ) in the EPM, respectively. Main effects of stress in adolescence (F 1,35 ¼ 163.79, po0.05) and stress in adulthood (F 1,35 ¼ 155.39, po0.05) and a stress in adolescence Â stress in adulthood interaction (F 1,35 ¼ 7.65, po0.05) were found for immobility in the FST (Figure 7i) .
One day after the behavioral tests, the brains were removed, and six samples were randomly selected for subsequent western blot (n ¼ 6 per group; Wang et al, 2010) . The data analysis showed that PCMS during adolescence increased phospho-mTOR and phospho-rpS6 levels in the PFC (po0.05; Figure 8a and c), and CUS in adulthood decreased phospho-mTOR and phospho-rpS6 levels in the PFC (po0.05; Figure 8a and c). PCMS during adolescence resisted the CUS-induced decrease in mTOR signaling activity in the PFC in adulthood, in which the levels of phospho-mTOR and phospho-rpS6 in the PCMS þ CUS group were not significantly changed compared with the no stress group (p40.05; Figure 8a and c). The analysis revealed main effects of stress in adolescence (F 1,20 ¼ 162.37, po0.05; F 1,20 ¼ 161.61, po0.05) and stress in adulthood (F 1,20 ¼ 159.28, po0.05; F 1,20 ¼ 146.27, po0.05) and a stress in adolescence Â stress in adulthood interaction (F 1,20 ¼ 5.15, po0.05; F 1,20 ¼ 12.35, po0.05) for phospho-mTOR and phospho-rpS6 levels in the PFC, respectively (Figure 8a and c) . Total mTOR and rpS6 levels were not significantly changed in the PFC in the four groups (p40.05; Figure 8b and d) .
Altogether, these results suggest that PCMS during adolescence resisted the depressive-and anxiety-like behavior induced by CUS in adulthood, and PCMS during adolescence resisted the CUS-induced decrease in mTOR signaling activity in the PFC in adulthood.
DISCUSSION
This study showed that PCMS during adolescence promoted antidepressant-and anxiolytic-like effects in early adulthood, and mTOR signaling in the PFC played an important role in these processes. Moreover, PCMS during adolescence enhanced the ability to resist depressive-and anxietylike behavior induced by CUS in adulthood.
PCMS is a mild and chronic stressor and that occurs predictably. We found that PCMS in adolescence had no effect on body weight gain, contrary to previous studies that found that adolescent rodents were more sensitive to stressinduced weight loss (Chiba et al, 2012) . These results suggest that PCMS in adolescence had no effect on physical development from adolescence to adulthood. Furthermore, PCMS in adolescence resisted anhedonia-, despair-, and anxiety-like behavior in the SPT, FST, NSFT, and EPM. The resilience associated with PCMS did not focus on the absence of depressive-and anxiety-like behavior, but promoted antidepressant-and anxiolytic-like effects that depend on active resilience mechanisms (Russo et al, 2012) . Several underlying mechanisms of the resilience associated with PCMS in adolescence may be proposed. One mechanism involves the characteristics of the stressor, including controllability, predictability, ambiguity, chronicity, and intermittence (Anisman and Matheson, 2005) . Unpredictability refers to an event that will happen, but its occurrence is not signaled by environmental cues (Anisman and Matheson, 2005) . In human and animal studies, predictable and unpredictable stressors may have different effects. Unpredictable events are generally thought to have more aversive effects than predictable events. Unpredictable events are more likely to provoke excessive brain monoamine utilization (Tsuda et al, 1989) , variations in stress-related hormones (De Boer et al, 1989) , disturbances in immune functioning (Mormede et al, 1988) , and changes in blood pressure (Lawler et al, 1993) . Consistent with previous studies, the stressor used in our study was predictable. Exposure during adolescence produced resistance to depressive-and anxiety-like behavior in adulthood. However, many other chronic restraint stress procedures have been shown to cause depressive-and anxiety-like behavior ( All of the behavioral tests were separated by 1 day and conducted sequentially after stress exposure. We assessed the effects of PCMS and CUS on (b) body weight gain, (c) depressive-like behavior in the sucrose preference test (SPT), (d) locomotor activity, (e, f) anxiety-like behavior in the novelty-suppressed feeding test (NSFT), reflected by the latency to feed and food consumption during 5 min in the home cages, (g, h) anxiety-like behavior in the elevated plus maze (EPM), and (i) depressive-like behavior in the forced swim test (FST). The data are expressed as mean ± SEM (n ¼ 9-10 per group). *po0.05, compared with the control group; # po0.05, PCMS þ CUS group compared with PCMS þ control group; & po0.05, PCMS þ CUS group compared with the CUS group. LA, locomotor activity. Swiergiel et al, 2007) . Although these stress procedures were predictable, the excessive intensity and duration of the stressor exceeded the endurance of organism, which may result in a much greater increase in corticosterone levels and aberrant adaptation, thus making the organism unable to cope with life changes, eventually leading to depressiveand anxiety-like behavior. A second explanation for these results is that stress during adolescence determines behavioral strategies to cope with subsequent stressors in adulthood. The brain undergoes extensive morphological and functional remodeling in adolescence (Casey et al, 2008; Spear, 2000) . Risk and protective factors during development greatly impact brain development and shape neural circuits that regulate future responses to stress and adversity (Southwick and Charney, 2012) . Stressful events during early life were associated with later non-adaptive behaviors (Spear, 2000) and represented a significant risk factor for the development of mental disorders in later life (Heim and Nemeroff, 2001 ). Many studies in animal models found that juvenile stress protocols resulted in long-lasting alterations in stress responses and depressive-and anxiety-like behavior in adulthood (Tsoory et al, 2007) . For example, rats exposed to chronic juvenile stress (ie, 6 h restraint daily from PNDs 20 to 41) exhibited anhedonia, reflected by sucrose preference (Eiland et al, 2012) . In contrast, mild-to-moderate stressors that are controllable can have an inoculating effect (Levine, 1962) and help adolescents develop adaptive stress responses and become more resilient to the negative effects of future stressors (Southwick and Charney, 2012) . Animal studies have shown that intermittent mother-offspring separation in squirrel monkeys produced fewer signs of anxiety and more exploration in a novel environment (Parker et al, 2004) . Maternal deprivation (PNDs 7-14), combined with CUS (ie, elevated platform, forced swim, and food deprivation; PNDs 28-84) promoted a greater degree of resilience to stress than maternal deprivation alone. Juvenile-onset CUS (PNDs 30-90) induced more resilience than adult-onset CUS (PNDs 60-90; Ricon et al, 2012) . Animals subjected to early stress during postnatal life and young adulthood exhibited enhanced hippocampal neurogenesis, decreased repressive histone methylation at brain-derived neurotrophic factor (BDNF) promoter IV, enhanced BDNF levels, and improved performance in the stress-associated Morris water maze. In contrast, middleaged early stress animals exhibited a reduction of neurogenesis and epigenetic modifications associated with decreased BDNF IV expression (Suri et al, 2012) . Thus, the characteristics, timing, duration, and severity of stressors are likely to be important factors in determining whether early experiences ultimately produce a protective or deleterious outcome. Our results also showed that PCMS in adolescence elevated mTOR signaling activity in the PFC. Rapamycin administration completely blocked the behavioral effects produced by PCMS in adolescence, indicating that mTOR signaling is involved in the PCMS-induced resilience to adolescence depression and anxiety in adulthood. The mTOR pathway has been shown to play an important role in depression. The majority of evidence of mTOR function comes from studies that utilized rapamycin (Li et al, , 2011 . Rapamycin inhibits mTOR signaling (Kim et al, 2002) . Recent animal studies showed that chronic treatment with the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 activated mTOR and related proteins in rat cortical tissue (Yoon et al, 2008) . Li et al (2010) reported that the NMDA receptor antagonist ketamine, a fast-acting antidepressant, rapidly activated the mTOR signaling pathway, leading to increased synaptic signaling proteins and an increased number and function of new spine synapses in the PFC in rats. Li et al (2011) also found that a single dose of ketamine rapidly reversed the behavioral and synaptic deficits caused by long-term CUS exposure in an mTORdependent manner. Other studies found robust deficits in the mTOR signaling pathway in the PFC in subjects clinically diagnosed with major depressive disorder (Jernigan et al, 2011) and reduced the phosphorylation of mTOR signaling pathway components in the amygdala in rats exposed to CUS (Chandran et al, 2012) . Therefore, activation of the mTOR pathway may be related to antidepressant actions.
In addition, our findings showed that PCMS in adolescence resisted the depressive-and anxiety-like effects of CUS in adulthood. The CUS model of depression has high validity (Willner, 1997) , and numerous studies have confirmed that CUS increases depressive-and anxiety-like behavior (Zhu et al, 2011) . In this study, PCMS in adolescence not only resisted acute stress in the FST but also resisted chronic stress-induced mood deficits.
The effects of PCMS in adolescence that resisted the effects of CUS in adulthood may be mediated by adaptive neurobiological changes, such as the modulation of mTOR signaling, activation of glutamatergic signaling (Adamec et al, 2012) , modulation of the hypothalamic-pituitaryadrenal axis (Romeo et al, 2007) , elevation of corticosterone levels at an optimal level (Feder et al, 2009) , elevation of neuropeptide Y levels (Cohen et al, 2012) , and enhancement of hippocampal neurogenesis (Joels, 2008; Toth et al, 2008) , thus leading to adaptation and resistance and making the organism better able to cope with impending challenges (Parihar et al, 2011) .
The processes by which PCMS in adolescence increases resilience in adulthood may involve alterations in the neural encoding of action in limbic circuitry. A recent study provided circuit-level insights into the causal dynamics of depressionrelated behavior (Tye et al, 2013) . Our future studies will target specific circuits and continue to advance our understanding of the biological bases of stress and resilience.
Our findings indicate that specific adolescent stress exposure may improve the ability to deal with stressful experiences in adulthood and not impair the ability to cope with stress. The findings also suggest that mTOR signaling may be a potential target for the development of new treatments for stress-associated mental disorders.
